Literature DB >> 22496431

Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.

Jung-Lye Kim1, Sin-Hye Park, Daewon Jeong, Ju-Suk Nam, Young-Hee Kang.   

Abstract

Bone-remodeling imbalance induced by increased bone resorption and osteoclast formation is known to cause skeletal diseases such as osteoporosis. There has been growing interest in the anabolic natural agents that enhance bone formation. Silymarin is flavonolignans extracted from blessed milk thistle. Several studies suggest that silymarin possesses antihepatotoxic properties and anticancer effects against carcinoma cells. This study investigated promoting effects of silymarin on differentiation and mineralization of osteoblastic MC3T3-E1 mouse cells and on bone mineral density (BMD) by in vivo fracture experiments. Osteoblasts were treated with 1-20 μmol/L silymarin for 15 days in a differentiating medium. In addition, this study explored signaling pathways implicated in the osteoblastogenesis of silymarin. It was found that silymarin stimulated alkaline phosphatase (ALP) activity and calcium nodule formation in a dose-dependent manner with a substantial effect on osteoblast proliferation. Silymarin treatment enhanced collagen secretion, osteocalcin transcription and bone morphogenetic protein (BMP) expression. The BMP inhibitor noggin suppressed the silymarin-promoted ALP activity in differentiated osteoblasts, suggesting that its osteoblastogenic actions entail the BMP pathway. This was proved by increased SMAD1/5/8 phosphorylation and runt-related transcription factor 2 (Runx2) expression in the presence of silymarin. In 21-day fracture-healing experiments, fractured and silymarin (10 mg/kg)-treated C57BL/6 mice showed better bone healing than fractured mice. Silymarin supplementation improved tibial bone strength with elevated BMD and serum levels of osteogenic ALP and osteocalcin. Taken together, these results demonstrate, for the first time, that silymarin has a potential to enhance osteoblastogenesis through accelerating BMP/SMAD/Runx2 signal pathways and to improve fracture healing and bone strength in mouse tibiae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496431     DOI: 10.1258/ebm.2011.011376

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  9 in total

1.  NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts.

Authors:  Bin Wang; Yanmei Yang; Li Liu; Harry C Blair; Peter A Friedman
Journal:  Bone       Date:  2012-10-07       Impact factor: 4.398

Review 2.  Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Authors:  Elisa Torre
Journal:  Phytochem Rev       Date:  2017-08-31       Impact factor: 5.374

Review 3.  Emerging Natural-Product-Based Treatments for the Management of Osteoarthritis.

Authors:  Maria-Luisa Pérez-Lozano; Annabelle Cesaro; Marija Mazor; Eric Esteve; Sabine Berteina-Raboin; Thomas M Best; Eric Lespessailles; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2021-02-09

4.  Tenogenic effects of silymarin following experimental Achilles tendon transection in rats.

Authors:  Hazhir Soleimani; Mehdi Behfar; Rahim Hobbenaghi
Journal:  Vet Res Forum       Date:  2021-03-15       Impact factor: 1.054

5.  Aesculetin Accelerates Osteoblast Differentiation and Matrix-Vesicle-Mediated Mineralization.

Authors:  Woojin Na; Min-Kyung Kang; Sin-Hye Park; Dong Yeon Kim; Su Yeon Oh; Moon-Sik Oh; Sohyun Park; Ii-Jun Kang; Young-Hee Kang
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

6.  KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK.

Authors:  Laura Salvadori; Maria Laura Belladonna; Beatrice Castiglioni; Martina Paiella; Eleonora Panfili; Tommaso Manenti; Catia Ercolani; Luca Cornioli; Sara Chiappalupi; Giulia Gentili; Massimiliano Leigheb; Guglielmo Sorci; Michela Bosetti; Nicoletta Filigheddu; Francesca Riuzzi
Journal:  Nutrients       Date:  2022-07-25       Impact factor: 6.706

7.  Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.

Authors:  Jung-Lye Kim; Yun-Ho Kim; Min-Kyung Kang; Ju-Hyun Gong; Seoung-Jun Han; Young-Hee Kang
Journal:  Biomed Res Int       Date:  2013-05-28       Impact factor: 3.411

Review 8.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21

9.  Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.

Authors:  Eun-Jung Lee; Min-Kyung Kang; Yun-Ho Kim; Dong Yeon Kim; Hyeongjoo Oh; Soo-Il Kim; Su Yeon Oh; Woojin Na; Young-Hee Kang
Journal:  Biomolecules       Date:  2020-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.